CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

NCT07659704 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

BIOLOGICAL: Autologous CD19-Directed CAR-T Cells Manufactured at Ribeirão Preto Blood Center

Sponsor

University of Sao Paulo

Collaborators

[object Object]